Remedica is specialised in the development and supply of pharmaceutical products for out-licensing. It offers attractive out-licensing opportunities to companies throughout the globe in a wide range of therapeutic areas. The offered dossiers comply with all applicable international and European standards. Together with you, Remedica will work towards the most cost effective solution aiming to be a sustainable partner that offers tailored solutions according to your specific needs and requirements.

Abacavir / Lamivudine600mg / 300mgFilm-coated TabletsAntiviral for systemic use
Anastrozole1mgFilm-coated TabletsEndocrine therapy (hormone antagonist)
Atazanavir100mg, 150mg, 200mg, 300mgFilm-coated TabletsAntiviral
Capecitabine150mg, 500mgFilm-coated TabletsAnti-neoplastic agent
Cinacalcet30mg, 60mg, 90mgFilm-coated TabletsCalcium Homeostasis (Anti-parathyroid agent)
Darunavir75mg, 150mg, 300mg , 400mg, 600mg, 800mgFilm-coated TabletsAntiviral for systemic use
Efavirenz / Emtricitabine / Tenofovir Disoproxil600mg / 200mg / 245mgFilm-coated TabletsAntiviral for systemic use
Emtricitabine / Tenofovir Disoproxil200mg / 245mgFilm-coated TabletsAntiviral for systemic use
Entecavir0.5mg, 1mgFilm-coated TabletsAntiviral for systemic use
Erlotinib25mg, 50mg, 100mg, 150mgFilm-coated TabletsAntineoplastic agent
Exemestane25mgFilm-coated TabletsEndocrine therapy (hormone antagonist)
Gefitinib250mgFilm-coated TabletsAntineoplastic agent
Imatinib100mg, 400mgFilm-coated TabletsAntineoplastic agent
Ivabradine5mg, 7.5mgFilm-coated TabletsCardiac therapy
Phenoxymethylpenicillin800mg, 1000mgFilm-coated TabletsAntibacterial for systemic use
Rasagiline1mgTabletsAnti-Parkinson drug
Sunitinib12.5mg, 25mg, 37.5mg, 50mgCapsulesAntineoplastic agent
Tenofovir Disoproxil123mg, 163mg, 204mg, 245mgFilm-coated TabletsAntiviral for systemic use

*Patent Information: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.